News & Analysis on Clinical Trial Services & Contract Research And Development
BIO 2019
Last year saw heightened market volatility, marked by international trade disputes, regulatory unrest, and a general feeling of uncertainty – but 2019 is off to a strong start with several multi-billion dollar deals.
Cytonus will present at BIO regarding the development of Cargocytes, which offer a delivery system for immunotherapy treatments.
Translational research faces new challenges – and opportunities – with the rapid growth in precision medicine and new drug modalities, as the industry looks to quickly bring new treatments to patients.
Vetter’s German sites will be supplied with only CO2 neutral energy from renewable energy sources as the company continues to work towards greater sustainability.
Partnership with German Red Cross will see Rexgenero’s lead drug candidate reaching broader patient base in clinical trials.
Although the industry may not be among the ‘frontrunners’, Novo Nordisk is seeing the benefits when it comes to recruitment and developing mutually beneficial partnerships, says director.